Literature DB >> 2875129

Effects of arachidonic acid on glutamate and gamma-aminobutyric acid uptake in primary cultures of rat cerebral cortical astrocytes and neurons.

A C Yu, P H Chan, R A Fishman.   

Abstract

The effects of arachidonic acid on glutamate and gamma-aminobutyric acid (GABA) uptake were studied in primary cultures of astrocytes and neurons prepared from rat cerebral cortex. The uptake rates of glutamate and GABA in astrocytic cultures were 10.4 nmol/mg protein/min and 0.125 nmol/mg protein/min, respectively. The uptake rates of glutamate and GABA in neuronal cultures were 3.37 nmol/mg protein/min and 1.53 nmol/mg protein/min. Arachidonic acid inhibited glutamate uptake in both astrocytes and neurons. The inhibitory effect was observed within 10 min of incubation with arachidonic acid and reached approximately 80% within 120 min in both types of culture. The arachidonic acid effect was not only time-dependent, but also dose-related. Arachidonic acid, at concentrations of 0.015 and 0.03 mumol/mg protein, significantly inhibited glutamate uptake in neurons, whereas 20 times higher concentrations were required for astrocytes. The effects of arachidonic acid were not as deleterious on GABA uptake as on glutamate uptake in both astrocytes and neurons. In astrocytes, GABA uptake was not affected by any of the doses of arachidonic acid studied (0.015-0.6 mumol/mg protein). In neuronal cultures, GABA uptake was inhibited, but not to the same degree observed with glutamate uptake. Lower doses of arachidonic acid (0.03 and 0.015 mumol/mg protein) did not affect neuronal GABA uptake. Other polyunsaturated fatty acids, such as docosahexaenoic acid, affected amino acid uptake in a manner similar to arachidonic acid in both astrocytes and neurons. However, saturated fatty acids, such as palmitic acid, exerted no such effect. The significance of the arachidonic acid-induced inhibition of neurotransmitter uptake in cultured brain cells in various pathological states is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875129     DOI: 10.1111/j.1471-4159.1986.tb00738.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  25 in total

1.  Cloning and identification of differentially expressed transcripts in primary culture of GABAergic neurons.

Authors:  Z Li; Q Li; C X Sun; L Hertz; A C Yu
Journal:  Neurochem Res       Date:  2001-10       Impact factor: 3.996

2.  Identification of transcripts expressed under functional differentiation in primary culture of cerebral cortical neurons.

Authors:  Qiang Li; Zhi Li; Chun-Xiao Sun; Albert Cheung-Hoi Yu
Journal:  Neurochem Res       Date:  2002-02       Impact factor: 3.996

3.  The contribution of arachidonic acid to the aetiology and pathophysiology of focal brain oedema; studies using an infusion oedema model.

Authors:  I R Whittle; I R Piper; J D Miller
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

4.  Effects of palmitate on astrocyte amino acid contents.

Authors:  M Yudkoff; I Nissim; I Nissim; J Stern; D Pleasure
Journal:  Neurochem Res       Date:  1989-04       Impact factor: 3.996

Review 5.  Phospholipases A2 in ischemic and toxic brain injury.

Authors:  A Sapirstein; J V Bonventre
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

6.  Distribution of GABA immunoreactivity in the retino-recipient layer of the viper optic tectum. A light and electron microscope quantitative study.

Authors:  J P Rio; J Repérant; M Herbin; D Miceli
Journal:  Anat Embryol (Berl)       Date:  1995-03

7.  Energy metabolism in hypoxic astrocytes: protective mechanism of fructose-1,6-bisphosphate.

Authors:  J A Kelleher; P H Chan; T Y Chan; G A Gregory
Journal:  Neurochem Res       Date:  1995-07       Impact factor: 3.996

8.  Effect of arachidonic acid on [3H]D-aspartate outflow in the rat hippocampus.

Authors:  M Simonato; G Bregola; C Bianchi; L Beani
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

9.  Cytosolic phospholipase A2 alpha inhibition prevents neuronal NMDA receptor-stimulated arachidonic acid mobilization and prostaglandin production but not subsequent cell death.

Authors:  Ava L Taylor; Joseph V Bonventre; Tracy F Uliasz; James A Hewett; Sandra J Hewett
Journal:  J Neurochem       Date:  2008-06-28       Impact factor: 5.372

Review 10.  Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease.

Authors:  Evelin L Schaeffer; Orestes V Forlenza; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-10-14       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.